SCHEMBL9152115

SCHEMBL9152115

CCN(CC)CCCCCCCCCCCC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.56
PPARG P37231 7/20 0.56
PPARD Q03181 7/20 0.56
PPARA Q07869 7/20 0.56
HDAC11 Q96DB2 5/20 0.56
TSHR P16473 5/20 0.56
PTPN1 P18031 3/20 0.56
ALDH1A1 P00352 2/20 0.56
TLR2 O60603 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
FABP4 P15090 2/20 0.56
SLC22A6 Q4U2R8 1/20 0.56
SLC22A8 Q8TCC7 1/20 0.56
MEN1 O00255 1/20 0.56
ESR1 P03372 1/20 0.56
ALOX15 P16050 1/20 0.56
PDE4A P27815 1/20 0.56
KMT2A Q03164 1/20 0.56
PDE3A Q14432 1/20 0.56
HSD17B10 Q99714 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9155100 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL710294 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL1772090 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL11621162 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL708830 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9148396 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
Hydrochloric Acid SCHEMBL6648801 0.98 KDM5A (0.54) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5393582 0.98 KDM5A (0.58) GPR84PPARGPPARDPPARAHDAC11
Hydrochloric Acid SCHEMBL6649565 0.95 KDM5A (0.56) GPR84PPARGPPARDPPARAHDAC11
Ammonia Solution, Strong SCHEMBL5785391 0.95 KDM5A (0.56) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5472946-A Topical administration of lincomycin, clindamycin, erthromycin and iododeoxyuridine on skin or mucuous membranes DISCOVERY THERAPEUTICS, INC. 1995-12-05 US disclosed
US-5470848-A Penetration enhancers for transdermal delivery of systemic agents DISCOVERY THERAPEUTICS, INC. 1995-11-28 US disclosed
US-5444075-A Penetration enhancers for transdermal delivery of systemic agents MINASKANIAN GEVORK (US) 1995-08-22 US disclosed
US-5391564-A E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents SANKYO COMPANY, LIMITED (JP) 1995-02-21 US disclosed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
US-5234959-A Omega-dialkylaminoalkanoic acids; drug delivery directly to the bloodstream WHITBY RESEARCH, INC. (US) 1993-08-10 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
US-5118676-A Administering carboxylic derivatives as enhancer with systemically active agents WHITBY RESEARCH, INC. (US) 1992-06-02 US disclosed
US-5118692-A Penetration enhances for transdermal delivery of systemic agents WHITBY RESEARCH, INC. (US) 1992-06-02 US disclosed
US-4996199-A Penetration enhancers for transdermal delivery of systemic agents WHITBY RESEARCH, INC. (US) 1991-02-26 US disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed
WO-1989011275-A1 PENETRATION ENHANCERS FOR TRANSDERMAL DELIVERY OF SYSTEMIC AGENTS NELSON RESEARCH & DEVELOPMENT CO. (US) 1989-11-30 WO disclosed